Patient Portals and Chronic Disease Management – #HITsm Chat Topic
We’re excited to share the topic and questions for this week’s #HITsm chat happening Friday, 1/26 at Noon ET (9 AM PT). This week’s chat will be hosted by Monica Stout (@MI_turnaround) from Medicasoft on the topic of “Patient Portals and Chronic Disease Management.” The Centers for Disease Control and Prevention posted a statistic stating that roughly 117 million people have one or more chronic health conditions. One in four people has two more chronic conditions. That is so many people! It’s 2018 and there are tons of innovative technologies out there. Why aren’t we doing a better job of managing our health conditions? In a recent blog, I posted that chronic disease management represents one of the best opportunities for a personal health record or patient portal to link wellness and healthcare together to affect positive health outcomes. What changes in healthcare technology need to be made to more effectively treat and manage patients with chronic conditions? Join us to talk about patient portals and chronic disease management during this week’s #HITsm chat. Topics for This Week’s #HITsm Chat: T1: Would you (or do you) use technology to help manage your health and wellness? Why or why not? #HITsm T2: Effectively managing chronic disease can involve changing habits and forming good habits. What are some ways IT can help patients form and maintain good habits? #HITsm T3: What’s a feature you wish patient ...
Publication date: Available online 16 November 2019Source: Journal of Health EconomicsAuthor(s): Dimitris Christelis, Dimitris Georgarakos, Anna Sanz-de-GaldeanoAbstractEconomic theory predicts that a reduction in background risk should induce financial risk-taking, particularly for individuals with low stock market participation costs. Hence, health insurance coverage could affect financial risk-taking by offsetting health-related background risk. We use a regression discontinuity design to examine whether Medicare eligibility at age 65 increases stockholding in the US and find that it does so for those with college educa...
In this study, serum IL6 was measured by ELISA, and the HSD11B1rs12086634(T/G) polymorphism was analyzed using a TaqMan allelic discrimination assay technique. There were statistically significant differences between the two studied groups concerning the serum IL-6 level and HSD11B1rs12086634(T/G) genotype distribution, with increased serum IL6 and increased frequencies of the GG and TG genotypes in patients with PCO. The GG genotype of HSD11B1 rs12086634(T/G) and its associated high level of serum IL-6 may represent genetic risk factors for PCOS.
Publication date: Available online 17 November 2019Source: European UrologyAuthor(s): Tom Marcelissen, Kevin Rademakers
Publication date: Available online 17 November 2019Source: European UrologyAuthor(s): Zhengzheng Xu, Guangzhe Ge, Bao Guan, Zhentao Lei, Xueyu Hao, Yuanyuan Zhou, Yue Shi, Huan Lu, Jilu Wang, Ding Peng, XiKang Wu, Huiying He, Bao Zhang, Xuesong Li, Liqun Zhou, Weimin Ci
Publication date: Available online 16 November 2019Source: European UrologyAuthor(s): Pirus Ghadjar, Thomas Wiegel
Publication date: Available online 16 November 2019Source: European UrologyAuthor(s): Elise De Bleser, Piet Ost
ConclusionThe CFQL-2 is a brief, reliable scale that effectively measures psychosocial aspects of QoL and is sensitive to changes in QoL in families of children with ASD or related neurodevelopmental disorders. Child externalizing behavior is strongly associated with reductions in multiple aspects of child and family psychosocial QoL.
ConclusionThis meta-analysis suggested a significant association between MTHFR gene polymorphism (C677T and A1298C) and ASD risk.
ConclusionGiven that obtaining negative margins is important in reducing the risk of recurrence, the method of surgical resection utilized is based on the amount of future functional residual hepatic parenchyma.
ConclusionsTattooing of axillary LNs is safe and easily performed. Tattooing was helpful in identifying the marked LN in the majority of cases. This technique helps to ensure that metastatic LNs are identified and removed at surgery after NAT.